What is the ICD-10 code for larynx cancer?

The ICD-10 code for larynx cancer varies by subsite: C32.0 for glottis, C32.1 for supraglottis, C32.8 for overlapping sites, and C32.9 for unspecified sites.

How do you code a laryngeal tumor with unspecified site?

Use ICD-10 code C32.9 for laryngeal tumors when the specific subsite cannot be determined from available documentation.

ICD-10 Coding for Larynx Cancer(C32.0, C32.1, C32.8)

Save

Explore detailed ICD-10 coding guidelines for larynx cancer, including specific codes for glottis, supraglottis, and overlapping sites. Ensure accurate documentation and compliance.

Also known as:

Laryngeal CancerCancer of the Larynx

Related ICD-10 Code Ranges

Complete code families applicable to Larynx Cancer

C00-D49Primary Range

Neoplasms

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
C32.0	Malignant neoplasm of glottis	Use when the tumor is located in the glottis, involving true vocal cords.	Laryngoscopy images showing vocal cord lesion Biopsy report specifying 'glottic'
C32.1	Malignant neoplasm of supraglottis	Use when the tumor is located in the supraglottis.	Imaging confirming supraglottic mass Biopsy report specifying 'supraglottic'
C32.8	Malignant neoplasm of overlapping sites of larynx	Use when the tumor spans multiple laryngeal subsites.	Operative note indicating tumor spans multiple subsites Diagrammatic mapping of tumor location
C32.9	Malignant neoplasm of unspecified site of larynx	Use only when the specific subsite cannot be determined.	Pathology report stating 'larynx' without subsite Negative imaging for localization

Primary ICD-10-CM Codes

Malignant neoplasm of glottis

C32.0Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Malignant neoplasm of supraglottisC32.1

Malignant neoplasm of glottisC32.0

Malignant neoplasm of unspecified site of larynxC32.9

Documentation & Coding Risks

Avoid these common issues when documenting Larynx Cancer.

Failing to document tumor laterality

Impact

Clinical: May affect treatment planning and surgical approach., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.

Mitigation

Ensure laterality is documented in all relevant reports, Use templates that prompt for laterality

Using C32.9 when specific subsite information is available.

Impact

Reimbursement: May lead to incorrect DRG assignment, affecting reimbursement., Compliance: Non-compliance with coding guidelines requiring specificity., Data Quality: Decreases accuracy of clinical data used for research and treatment planning.

Mitigation

Query the provider for specific subsite details if not documented.

Unspecified Site Coding

Impact

Using C32.9 without documented rationale for unspecified site.

Mitigation

Implement queries to obtain specific subsite information.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with C32.0.

Primary Code

C32.0

Malignant neoplasm of glottis

Quick Navigation

ICD-10 codes7

Coding risks3

FAQs2

ICD-10 Coding for Larynx Cancer(C32.0, C32.1, C32.8)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for larynx cancer?

How do you code a laryngeal tumor with unspecified site?

Related condition guides